VHCP Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

VHCP Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.92M	Buy	912,050 +55,500	+6%	+$130K	2.06%	11
2016 Q3	$2.26M	Buy	856,550 +60,000	+8%	+$150K	2.22%	10
2016 Q2	$1.51M	Hold	796,550	–	–	1.57%	14
2016 Q1	$2.34M	Buy	796,550 +92,820	+13%	+$265K	2.03%	9
2015 Q4	$2.2M	Hold	703,730	–	–	1.33%	12
2015 Q3	$2.22M	Hold	703,730	–	–	0.57%	18
2015 Q2	$2.67M	Hold	703,730	–	–	0.75%	18
2015 Q1	$3.31M	Hold	703,730	–	–	0.76%	19
2014 Q4	$4.48M	Hold	703,730	–	–	1.23%	14
2014 Q3	$3.45M	Hold	703,730	–	–	1.55%	16
2014 Q2	$5.38M	Hold	703,730	–	–	2.87%	11
2014 Q1	$7.42M	Hold	703,730	–	–	3.86%	9
2013 Q4	$9.14M	Buy	+703,730	New	+$6.57M	4.92%	8

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VHCP Management's OCRX Position: Q4 2016 in Review

VHCP Management increased its Ocera Therapeutics, Inc. (OCRX) stake by 6.5% in Q4 2016, buying an estimated $130K and bringing the position to 912,050 shares worth $1.92M. The position accounts for 2.06% of the portfolio, ranked #11.

VHCP Management first reported a position in OCRX in Q4 2013 and has held it in 13 quarters since. The position peaked at $9.14M in Q4 2013. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

VHCP Management held 912,050 shares of Ocera Therapeutics, Inc. worth $1.92M as of Q4 2016.
VHCP Management bought 55,500 Ocera Therapeutics, Inc. shares in Q4 2016, an estimated $130K.
Ocera Therapeutics, Inc. made up 2.06% of VHCP Management's portfolio in Q4 2016, its #11 holding.
VHCP Management first reported a position in Ocera Therapeutics, Inc. in Q4 2013 and has held it in 13 quarters since.
VHCP Management's Ocera Therapeutics, Inc. position peaked at $9.14M in Q4 2013.
36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.